News & Events
-
A look ahead to what 2021 holds for PredictTB
Four years into the project, PredictTB is entering a new phase. In 2021, the project hopes to begin preliminary data analyses. Over the next one and a half years, PredictTB’s scientists will look at datasets from the study’s more than 600 participants. Simultaneously, new patients will be recruited for PredictTB’s MRI sub-study. This article... -
Evaluate4mTB: Taps the power of artificial intelligence to automate analysis of patient scans
Evaluate4mTB, a sub-study of PredictTB, is developing and testing a new machine learning algorithm to automate the analysis of tuberculosis patient scans. Led by Dr Stephanus Malherbe from Stellenbosch University, Evaluate4mTB aims to complement its parent study by providing additional analyses of scans from all PredictTB’s 516 participants,... -
WHO publishes report on the progress towards global TB targets
Last week, two years after the UN High Level Meeting (UNHLM) on Tuberculosis, the WHO and partners released a progress report to take stock of progress made in meeting the WHO’s End TB strategy, Sustainable Development Goals, and UNHLM targets for TB. -
ASSURE: Assessing the potential correlation between altered MTB cells and a patient’s risk for relapse
ASSURE aims to assess if TB patients who are considered clinically cured have completely achieved sterilisation at the end of treatment. Dr Caroline Beltran, ASSURE Study Lead, is looking for the presence of metabolically altered TB bacteria in sputum samples from PredictTB patients who have completed anti-TB treatment and the potential... -
EDCTP Annual Report 2019 – steering a portfolio for impact
PredictTB's funder, the European & Developing Countries Clinical Trials Partnership (EDCTP), published its Annual Report 2019 on August 14, 2020. The report shows the steady growth, scope, and cohesion of the project portfolio, and highlights the progress made towards the objectives of the programme. -
Patient recruitment for PredictTB clinical trial expected to restart in July 2020
Patient recruitment for PredictTB clinical trial in South Africa is scheduled to restart within the next month after having been at a halt since the end of March this year. The on-site staffers are already getting ready to welcome back patients by ensuring that everyone has the right personal protective equipment (PPE) to handle both TB and... -
EDCTP’s video highlights the work of PredictTB: Tuberculosis - one step further
The European and Developing Countries Clinical Trials Partnership (EDCTP) recently published a video highlighting the work of three of its tuberculosis (TB) projects, including PredictTB. Apart from PredictTB, which aims to assess new diagnostics for shortened TB therapy, PanACEA and POR-TB were highlighted in the video. PanACEA aims to develop... -
Global PredictTB Meeting 2019 in Shanghai
From 23 to 25 May 2019, the global PredictTB consortium convened for a progress and networking meeting in Shanghai, China. Meetings bringing together the overall consortium, including management teams, take place every year and serve the purpose of coordinating project activities at the global level. On the first day, the consortium assessed the...